BioTime (BTX) Tops Q2 EPS by 5c
Tweet
Share
E-mailBioTime (NYSE: BTX) reported Q2 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $557 thousand.
For earnings history and earnings-related data on BioTime (BTX) click here.
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
